Palomino Laboratories (PALX) Gains from Sales and Divestitures (2025)
Palomino Laboratories' (PALX) quarterly Gains from Sales and Divestitures came in at $370834.0 in Q3 2025.
Palomino Laboratories (PALX) Gains from Sales and Divestitures (2025) Analysis & Trends
Palomino Laboratories has disclosed Gains from Sales and Divestitures across 1 years of filings, most recently posting $370834.0 for Q3 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 370,834.00 |
| Sep 30, 2025 | 370,834.00 |